We are live on ! Find out more
AL

Arnhold LLC Portfolio holdings

AUM $1.36B
1-Year Est. Return 53.52%
This Fund
S&P 500
This Quarter Est. Return
+6.64%
1 Year Est. Return
+53.52%
3 Year Est. Return
+132.63%
5 Year Est. Return
+131.8%
10 Year Est. Return
AUM
$883M
AUM Growth
+$16.1M
Cap. Flow
-$38.1M
Cap. Flow %
-4.32%
Top 10 Hldgs %
41.42%
Holding
139
New
4
Increased
26
Reduced
37
Closed
7

Top Buys

Rank Stock Value
1
KD icon
Kyndryl
KD
+$12.3M
2
BMY icon
Bristol-Myers Squibb
BMY
+$7.48M
3
T icon
AT&T
T
+$5.53M
4
VTRS icon
Viatris
VTRS
+$4.62M
5
SLM icon
SLM Corp
SLM
+$4.54M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.3M
2
GLD icon
SPDR Gold Trust
GLD
+$11.9M
3
IHC
Independence Holding Company
IHC
+$8.31M
4
PGR icon
Progressive
PGR
+$8.19M
5
SNOW icon
Snowflake
SNOW
+$6.18M

Sector Composition

Rank Sector Weight
1 Technology 19.81%
2 Financials 14.61%
3 Consumer Discretionary 12.01%
4 Healthcare 9.77%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTRS icon
26
Viatris
VTRS
$20.1B
$13.2M 1.5%
978,036
+346,006
+55% +$4.62M
AVGO icon
27
Broadcom
AVGO
$1.82T
$13.2M 1.49%
197,970
-88,450
-31% -$4.97M
SEE
28
DELISTED
Sealed Air
SEE
$12.9M 1.46%
190,602
-2,907
-2% -$181K
ABBV icon
29
AbbVie
ABBV
$458B
$12.5M 1.42%
92,490
-42,575
-32% -$5.03M
WHR icon
30
Whirlpool
WHR
$2.42B
$12.2M 1.38%
52,039
+12,149
+30% +$2.67M
DAR icon
31
Darling Ingredients
DAR
$9.93B
$12.1M 1.37%
174,315
+44,545
+34% +$3.24M
BAC icon
32
Bank of America
BAC
$435B
$11M 1.24%
246,811
-21,921
-8% -$999K
UNH icon
33
UnitedHealth
UNH
$382B
$10.4M 1.17%
20,649
-5,883
-22% -$2.66M
KD icon
34
Kyndryl
KD
$2.66B
$10.3M 1.16%
+568,053
New +$12.3M
PFE icon
35
Pfizer
PFE
$140B
$9.51M 1.08%
161,091
-119,094
-43% -$5.9M
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.07T
$9.42M 1.07%
31,490
-4,127
-12% -$1.18M
DISCK
37
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$9.03M 1.02%
394,087
+42,659
+12% +$1.03M
ADT icon
38
ADT
ADT
$5.16B
$8.62M 0.98%
1,025,038
-172,740
-14% -$1.47M
MTB icon
39
M&T Bank
MTB
$36.2B
$8.07M 0.91%
52,541
-3,500
-6% -$537K
SLV icon
40
iShares Silver Trust
SLV
$28.1B
$6.53M 0.74%
303,575
AAPL icon
41
Apple
AAPL
$4.89T
$6.49M 0.74%
36,547
+27
+0.1% +$4.27K
JEF icon
42
Jefferies Financial Group
JEF
$12.9B
$4.95M 0.56%
133,550
KLIC icon
43
Kulicke & Soffa
KLIC
$5.3B
$4.84M 0.55%
80,000
JNJ icon
44
Johnson & Johnson
JNJ
$635B
$4.27M 0.48%
24,967
AMZN icon
45
Amazon
AMZN
$2.5T
$3.63M 0.41%
21,760
CYD icon
46
China Yuchai International
CYD
$1.69B
$3.56M 0.4%
238,365
-61,635
-21% -$776K
PSTH
47
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$3.28M 0.37%
166,151
+23,900
+17% +$474K
MO icon
48
Altria Group
MO
$122B
$3.21M 0.36%
67,695
BEN icon
49
Franklin Resources
BEN
$16.9B
$3.15M 0.36%
94,216
CBOE icon
50
Cboe Global Markets
CBOE
$29.8B
$2.86M 0.32%
21,935

Similar funds

Arnhold LLC's Q4 2021 Portfolio in Review

As of Q4 2021, Arnhold LLC held 139 positions worth $883M, up 1.9% from $867M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Arnhold LLC withdrew a net $38.1M in Q4 2021, closing 7 positions and reducing 37 holdings. Its most notable exit was Progressive, an estimated $8.19M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Arnhold LLC opened a new position in Kyndryl worth $10.3M.

  • Arnhold LLC's largest Q4 2021 buy was Kyndryl: 568,053 shares worth $10.3M.
  • Arnhold LLC added most to Bristol-Myers Squibb in Q4 2021, an estimated $7.48M increase.
  • Arnhold LLC's biggest Q4 2021 reduction was Merck, cutting an estimated $12.3M.
  • Arnhold LLC fully exited Progressive in Q4 2021, selling an estimated $8.19M.
  • Arnhold LLC's ten largest holdings make up 41% of its $883M portfolio in Q4 2021.
  • Arnhold LLC opened 4 new positions and closed 7 in Q4 2021.
  • Arnhold LLC's portfolio value rose 1.9% quarter-over-quarter to $883M.

Based on Arnhold LLC's 13F filing for Q4 2021, filed 8 Feb 2022.